Global consulting firm Elixirr International (LON:ELIX) delivered record H1 results. Revenues and pre-tax profits were both up 25% amid strong demand for the company’s artificial intelligence (AI), technology and commercial transformation services.
Margins continued to rise in H1. And founder CEO Stephen Newton insisted the scale of the opportunity ahead of his challenger consultancy is significant. ‘Industry research estimates that agentic AI alone could create up to $200 billion of new demand for technology services over the next five years’, he enthused.
So why did shares in Elixirr slump on Monday? Well, the absence of earnings upgrades and a rise in debt disappointed the market. In addition, the wording of the outlook statement spooked investors.
Elixirr expressed confidence that total adjusted EBITDA for FY26 will be in line with market expectations. However, it guided for revenue ‘broadly in line’ with consensus, which investors read to mean top-line growth might disappoint.
Record H1 results
Results for the half to June 2026 were outstanding. Revenue rose 25% to £89 million, adjusted EBITDA shot up 29% to £27.6 million and EBITDA margin improved from 30% to 31% year-on-year, demonstrating the scalability of Elixirr’s business model.
| H1 financial highlights | H126 | Change |
| Revenue (£m) | 89 | +25% |
| Adjusted EBITDA margin (%) | 31% | +1pp |
| Adjusted pre-tax profit (£m) | 25.1 | +25% |
| EPS (p) | 34.2 | +18% |
Source: Elixirr International, H1 results
Adjusted pre-tax profits powered 25% higher to £25.1 million. However, earnings per share (EPS) growth was a more modest 18%, reflecting a higher interest bill and an increased share count following acquisitions.
Breadth of growth drivers
Elixirr’s growth is being driven by deeper relationships with larger clients, investment in partners and capabilities, acquisitions and rapidly growing demand for AI-related services.
AI-related revenue increased 185% to £8.1 million with clients moving from experimentation towards larger-scale deployment and transformation programmes.
‘This breadth of growth drivers, combined with rising margins and the scalability of the platform, continues to strengthen the investment case,’ enthused Cavendish, which has a ‘buy’ rating and a £12.70 price target for the stock.
Today’s sell-off seems a harsh reaction to impressive results from this challenger consultancy.
Sharesify notes that Elixirr trades at a significant discount to peer Accenture (NYSE:ACN). This is despite the London-headquartered company seeing strong growth in AI-related work and continuing to deepen its largest client relationships.
Acquisitions are supplementing Elixirr’s organic growth. Kvadrant Consulting has established Elixirr’s first presence in the Nordics and added new capabilities, while TRC strengthened the group’s US business and achieved its full FY25 earn-out. Both acquisitions are creating opportunities to cross-sell capabilities and client relationships across the group.
Elixirr’s free cash flow in H1 was affected by working capital, bonus payments and tax timing, while acquisition payments increased net debt to £56.5 million. However, it is worth noting that Cavendish forecasts a reduction in net debt to £38 million by December 2026 and a return to net cash in FY28, ‘reflecting the strong underlying cash generation of the model’.
Disclaimer: The author James Crux has a personal interest in Elixirr International.
